Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Amgen
Biotech
Gilead Sciences
Topics

Advertisement

Amgen

Share

Top Latest Popular

Earlier Today

Shane Lowry confirms he will join Rory McIlroy at Amgen Irish Open The42 13:36

Amgen invests additional $300m to strengthen biomanufacturing in Puerto Rico European Pharmaceutical Review 12:17

‘Winning it again is always a goal’ - Shane Lowry confirmed for Amgen Irish Open at Doonbeg The Irish Independent 11:58

Advertisement

Advertisement

Yesterday

Amgen Expands Puerto Rico Biologics Facility With Additional $300M Investment Amid Tariff Pressure Barchart 01:11 Tue, 05 May

Monday

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks 15:00 Mon, 04 May

Amgen Announces Additional $300 Million U.S. Manufacturing Investment, Totaling Nearly $2 Billion Over The Last Year PR Newswire (Press Release) 14:03 Mon, 04 May

Sunday

Did Amgen’s Raised 2026 Outlook and AI-Focused Overhaul Just Shift AMGN’s Investment Narrative? Simply Wall St 11:03 Sun, 03 May

Friday

IRS Seeks More Taxes From Amgen, Adding to $10.7 Billion Dispute Bloomberg Law 16:31 Fri, 01 May

Thursday

Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates Zacks 23:20 Thu, 30 Apr

Regeneron Presses Amgen for Eylea Antitrust Damages Evidence Bloomberg Law 21:29 Thu, 30 Apr

Advertisement

In the last month

AZ, Amgen will pilot FDA's real-time clinical trial plan pharmaphorum 13:09 Wed, 29 Apr

Teva v. Lilly: Limiting Amgen’s Reach on Written Description and Enablement JD Supra 20:26 Tue, 28 Apr

Amgen to Report Q1 Earnings: Can It Keep the Beat Streak Alive? Zacks 18:16 Tue, 28 Apr

Did Amgen's Subsidiary Manipulate Data To Secure Tavneos Approval? RTT News 16:31 Tue, 28 Apr

FDA proposes to withdraw Amgen's drug for rare autoimmune diseases over effectiveness The Hindu Business Line 05:34 Tue, 28 Apr

Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a Well-Known... JD Supra 20:45 Mon, 27 Apr

Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks 23:55 Fri, 24 Apr

Well-Known Genus, Novel Method: A Post-Amgen Framework for Written Description & Enablement JD Supra 21:57 Fri, 24 Apr

Amgen Announces Webcast Of 2026 First Quarter Financial Results PR Newswire (Press Release) 21:05 Fri, 24 Apr

Amgen’s Chief Technology Officer Dr David Reese to retire European Pharmaceutical Review 16:28 Fri, 24 Apr

Biocon Launches Denosumab Biosimilars JD Supra 17:18 Thu, 23 Apr

Amgen Announces Retirement Of David M. Reese, Executive Vice President And Chief Technology Officer PR Newswire (Press Release) 21:01 Wed, 22 Apr

Biocon Launches Denosumab Biosimilars Bosaya™ / Aukelso™ in the United States JD Supra 17:58 Tue, 21 Apr

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks 15:09 Tue, 21 Apr

What to Expect From Amgen's Next Quarterly Earnings Report Barchart 16:56 Mon, 20 Apr

Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source South China Morning Post 08:03 Mon, 20 Apr

Amgen Korea pushes BiTE platform expansion into solid tumors with Imdelltra Korea Biomedical Review 02:46 Mon, 20 Apr

Will Amgen’s Subcutaneous Tepezza Success Reshape Viridian Therapeutics' (VRDN) Thyroid Eye Disease Narrative? Simply Wall St 10:43 Sun, 19 Apr

Is It Too Late To Consider Amgen (AMGN) After A 32% One-Year Share Price Rally? Simply Wall St 06:49 Sun, 19 Apr

Amgen (AMGN) Laps the Stock Market: Here's Why Zacks 23:57 Fri, 17 Apr

Amgen pipeline’s next growth cycle: replacing its old blockbusters Labiotech 14:10 Mon, 13 Apr

The biopharma senior associate whose career was fuelled by FUEL Silicon Republic 12:31 Sun, 12 Apr

Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again Zacks 18:11 Fri, 10 Apr

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider Zacks 23:58 Thu, 09 Apr

Amgen (AMGN) Beats Stock Market Upswing: What Investors Need to Know Zacks 00:09 Thu, 09 Apr

Amgen and Shanghai Henlius/Organon Settle Denosumab BPCIA Litigation JD Supra 18:05 Wed, 08 Apr

Amgen Settles BPCIA Litigation Against Henlius Over Prolia® / Xgeva® (denosumab) Biosimilars JD Supra 16:54 Wed, 08 Apr

Is Amgen (AMGN) Outperforming Other Medical Stocks This Year? Zacks 16:02 Tue, 07 Apr

AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease Zacks 16:02 Tue, 07 Apr

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks 15:10 Tue, 07 Apr

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna